Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Comparative Study of Confidence Intervals for Proportions in Complex Sample Surveys.

Franco C, Little RJA, Louis TA, Slud EV.

J Surv Stat Methodol. 2019 Sep;7(3):334-364. doi: 10.1093/jssam/smy019. Epub 2019 Jan 7.

2.

Bayesian Estimation of MSM Population Size in Côte d'Ivoire.

Datta A, Lin W, Rao A, Diouf D, Kouame A, Edwards JK, Bao L, Louis TA, Baral S.

Stat Public Policy (Phila). 2019;6(1):1-13. doi: 10.1080/2330443X.2018.1546634. Epub 2019 Mar 9.

3.

The Role of Expert Judgment in Statistical Inference and Evidence-Based Decision-Making.

Brownstein NC, Louis TA, O'Hagan A, Pendergast J.

Am Stat. 2019 Mar 20;73(1):56-68. doi: 10.1080/00031305.2018.1529623. eCollection 2019.

4.

Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins.

Daumit GL, Janssen EM, Jerome GJ, Dalcin AT, Charleston J, Clark JM, Coughlin JW, Yeh HC, Miller ER, Durkin N, Louis TA, Frick KD, Wang NY, Appel LJ.

Transl Behav Med. 2020 Feb 3;10(1):103-113. doi: 10.1093/tbm/iby120.

PMID:
30855082
5.

Subnational estimation of modern contraceptive prevalence in five sub-Saharan African countries: a Bayesian hierarchical approach.

Li Q, Louis TA, Liu L, Wang C, Tsui AO.

BMC Public Health. 2019 Feb 20;19(1):216. doi: 10.1186/s12889-019-6545-3.

6.

Discussion of "Randomization: The forgotten component of the randomized clinical trial".

Louis TA.

Stat Med. 2019 Jan 15;38(1):19-22. doi: 10.1002/sim.7923. No abstract available.

PMID:
30537121
7.

Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models.

Henderson NC, Louis TA, Rosner GL, Varadhan R.

Biostatistics. 2020 Jan 1;21(1):50-68. doi: 10.1093/biostatistics/kxy028.

PMID:
30052809
8.

Mathematical Modeling of "Chronic" Infectious Diseases: Unpacking the Black Box.

Fojo AT, Kendall EA, Kasaie P, Shrestha S, Louis TA, Dowdy DW.

Open Forum Infect Dis. 2017 Aug 14;4(4):ofx172. doi: 10.1093/ofid/ofx172. eCollection 2017 Fall. Erratum in: Open Forum Infect Dis. 2018 Jan 25;5(1):ofx206.

9.

Bayesian analysis of heterogeneous treatment effects for patient-centered outcomes research.

Henderson NC, Louis TA, Wang C, Varadhan R.

Health Serv Outcomes Res Methodol. 2016;16(4):213-233. Epub 2016 Sep 20.

10.

Perceived helpfulness of the individual components of a behavioural weight loss program: results from the Hopkins POWER Trial.

Dalcin AT, Jerome GJ, Fitzpatrick SL, Louis TA, Wang NY, Bennett WL, Durkin N, Clark JM, Daumit GL, Appel LJ, Coughlin JW.

Obes Sci Pract. 2015 Oct;1(1):23-32. Epub 2015 Sep 9.

11.

Perfluoroalkyl Chemicals, Menstrual Cycle Length, and Fecundity: Findings from a Prospective Pregnancy Study.

Lum KJ, Sundaram R, Barr DB, Louis TA, Buck Louis GM.

Epidemiology. 2017 Jan;28(1):90-98.

12.

Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.

Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group.

Ophthalmology. 2016 Jan;123(1):183-90. doi: 10.1016/j.ophtha.2015.09.022. Epub 2015 Oct 20.

13.

A Bayesian joint model of menstrual cycle length and fecundity.

Lum KJ, Sundaram R, Buck Louis GM, Louis TA.

Biometrics. 2016 Mar;72(1):193-203. doi: 10.1111/biom.12379. Epub 2015 Aug 21.

14.

Expand the toolkit!

Louis TA.

Am J Bioeth. 2015;15(4):40-2. doi: 10.1080/15265161.2015.1009571. No abstract available.

PMID:
25856599
15.

Willingness to pay for continued delivery of a lifestyle-based weight loss program: The Hopkins POWER trial.

Jerome GJ, Alavi R, Daumit GL, Wang NY, Durkin N, Yeh HC, Clark JM, Dalcin A, Coughlin JW, Charleston J, Louis TA, Appel LJ.

Obesity (Silver Spring). 2015 Feb;23(2):282-5. doi: 10.1002/oby.20981. Epub 2014 Dec 31.

16.

Estimation of treatment effects in matched-pair cluster randomized trials by calibrating covariate imbalance between clusters.

Wu Z, Frangakis CE, Louis TA, Scharfstein DO.

Biometrics. 2014 Dec;70(4):1014-22. doi: 10.1111/biom.12214. Epub 2014 Aug 27.

17.

Longitudinal accuracy of web-based self-reported weights: results from the Hopkins POWER Trial.

Jerome GJ, Dalcin A, Coughlin JW, Fitzpatrick S, Wang NY, Durkin N, Yeh HC, Charleston J, Pozefsky T, Daumit GL, Clark JM, Louis TA, Appel LJ.

J Med Internet Res. 2014 Jul 15;16(7):e173. doi: 10.2196/jmir.3332.

18.

Accounting for length-bias and selection effects in estimating the distribution of menstrual cycle length.

Lum KJ, Sundaram R, Louis TA.

Biostatistics. 2015 Jan;16(1):113-28. doi: 10.1093/biostatistics/kxu035. Epub 2014 Jul 14.

19.

Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.

Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.

20.

Evaluating local vegetation cover as a risk factor for malaria transmission: a new analytical approach using ImageJ.

Ricotta EE, Frese SA, Choobwe C, Louis TA, Shiff CJ.

Malar J. 2014 Mar 13;13:94. doi: 10.1186/1475-2875-13-94.

21.

On multi-marker tests for association in case-control studies.

Taub MA, Schwender HR, Younkin SG, Louis TA, Ruczinski I.

Front Genet. 2013 Dec 16;4:252. doi: 10.3389/fgene.2013.00252. eCollection 2013.

22.

An Exponential Tilt Mixture Model for Time-to-Event Data to Evaluate Treatment Effect Heterogeneity in Randomized Clinical Trials.

Wang C, Tan Z, Louis TA.

Biom Biostat Int J. 2014;1(2). pii: 00006. doi: 10.15406/bbij.2014.01.00006. Epub 2014 Sep 17.

23.

Eliminating central line-associated bloodstream infections: a national patient safety imperative.

Berenholtz SM, Lubomski LH, Weeks K, Goeschel CA, Marsteller JA, Pham JC, Sawyer MD, Thompson DA, Winters BD, Cosgrove SE, Yang T, Louis TA, Meyer Lucas B, George CT, Watson SR, Albert-Lesher MI, St Andre JR, Combes JR, Bohr D, Hines SC, Battles JB, Pronovost PJ; On the CUSP: Stop BSI program.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):56-62. doi: 10.1086/674384. Epub 2013 Nov 26.

PMID:
24334799
24.

Achieving and sustaining ventilator-associated pneumonia-free time among intensive care units (ICUs): evidence from the Keystone ICU Quality Improvement Collaborative.

Matar DS, Pham JC, Louis TA, Berenholtz SM.

Infect Control Hosp Epidemiol. 2013 Jul;34(7):740-3. doi: 10.1086/670989. Epub 2013 May 22.

PMID:
23739079
25.

Efficient simulation of epistatic interactions in case-parent trios.

Li Q, Schwender H, Louis TA, Fallin MD, Ruczinski I.

Hum Hered. 2013;75(1):12-22. doi: 10.1159/000348789. Epub 2013 Mar 27.

26.

Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial.

Rubin RR, Peyrot M, Wang NY, Coughlin JW, Jerome GJ, Fitzpatrick SL, Bennett WL, Dalcin A, Daumit G, Durkin N, Chang YT, Yeh HC, Louis TA, Appel LJ.

Qual Life Res. 2013 Nov;22(9):2389-98. doi: 10.1007/s11136-013-0363-3. Epub 2013 Mar 21.

27.

Health and school outcomes during children's transition into adolescence.

Forrest CB, Bevans KB, Riley AW, Crespo R, Louis TA.

J Adolesc Health. 2013 Feb;52(2):186-94. doi: 10.1016/j.jadohealth.2012.06.019. Epub 2012 Aug 27.

28.

Modification of the association between ambient air pollution and lung function by frailty status among older adults in the Cardiovascular Health Study.

Eckel SP, Louis TA, Chaves PH, Fried LP, Margolis AH.

Am J Epidemiol. 2012 Aug 1;176(3):214-23. doi: 10.1093/aje/kws001. Epub 2012 Jul 18.

29.

Incorporating genotype uncertainties into the genotypic TDT for main effects and gene-environment interactions.

Taub MA, Schwender H, Beaty TH, Louis TA, Ruczinski I.

Genet Epidemiol. 2012 Apr;36(3):225-34. doi: 10.1002/gepi.21615.

30.

From efficacy to effectiveness: lessons learned from the Practice-Based Opportunities for Weight Reduction (POWER) trial.

Jerome GJ, Rubin RR, Clark JM, Dalcin A, Coughlin JW, Yeh HC, Miller ER 3rd, Wang NY, Louis TA, Durkin N, Charleston J, Daumit GL, Appel LJ.

J Comp Eff Res. 2012 May;1(3):213-6. doi: 10.2217/cer.12.18. No abstract available.

31.

Why statistics?

Davidian M, Louis TA.

Science. 2012 Apr 6;336(6077):12. doi: 10.1126/science.1218685. No abstract available.

32.

Biometrics. Report of the editors--2011.

Louis TA, Millar R, Taylor JM, Verbeke G, Davidian M.

Biometrics. 2012 Mar;68(1):vii-x. doi: 10.1111/j.1541-0420.2012.01746.x. No abstract available.

PMID:
22443361
33.

Comparing treatments via the propensity score: stratification or modeling?

Myers JA, Louis TA.

Health Serv Outcomes Res Methodol. 2012 Mar;12(1):29-43.

34.

Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study.

Sutcliffe CG, Kobayashi T, Hamapumbu H, Shields T, Mharakurwa S, Thuma PE, Louis TA, Glass G, Moss WJ.

PLoS One. 2012;7(2):e31396. doi: 10.1371/journal.pone.0031396. Epub 2012 Feb 3.

35.

Comparative effectiveness of weight-loss interventions in clinical practice.

Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, Daumit G, Miller ER 3rd, Dalcin A, Jerome GJ, Geller S, Noronha G, Pozefsky T, Charleston J, Reynolds JB, Durkin N, Rubin RR, Louis TA, Brancati FL.

N Engl J Med. 2011 Nov 24;365(21):1959-68. doi: 10.1056/NEJMoa1108660. Epub 2011 Nov 15.

36.

Surrogate screening models for the low physical activity criterion of frailty.

Eckel SP, Bandeen-Roche K, Chaves PH, Fried LP, Louis TA.

Aging Clin Exp Res. 2011 Jun;23(3):209-16.

37.
38.

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE.

Ophthalmology. 2011 Oct;118(10):1916-26. doi: 10.1016/j.ophtha.2011.07.027. Epub 2011 Aug 15. Erratum in: Ophthalmology. 2012 Feb;119(2):212.

39.

A stochastic simulator of a blood product donation environment with demand spikes and supply shocks.

An MW, Reich NG, Crawford SO, Brookmeyer R, Louis TA, Nelson KE.

PLoS One. 2011;6(7):e21752. doi: 10.1371/journal.pone.0021752. Epub 2011 Jul 26.

40.

School outcomes of children with special health care needs.

Forrest CB, Bevans KB, Riley AW, Crespo R, Louis TA.

Pediatrics. 2011 Aug;128(2):303-12. doi: 10.1542/peds.2010-3347. Epub 2011 Jul 25.

41.

Paired comparison of observed and expected coronary heart disease rates over 12 years from the Atherosclerosis Risk in Communities Study.

Paynter NP, Sharrett AR, Louis TA, Rosamond W, Folsom AR, Coresh J.

Ann Epidemiol. 2010 Sep;20(9):683-90. doi: 10.1016/j.annepidem.2010.05.016.

42.

Independent but coordinated trials: insights from the practice-based Opportunities for Weight Reduction Trials Collaborative Research Group.

Yeh HC, Clark JM, Emmons KE, Moore RH, Bennett GG, Warner ET, Sarwer DB, Jerome GJ, Miller ER, Volger S, Louis TA, Wells B, Wadden TA, Colditz GA, Appel LJ.

Clin Trials. 2010 Aug;7(4):322-32. doi: 10.1177/1740774510374213. Epub 2010 Jun 23.

43.

Detection of SNP-SNP interactions in trios of parents with schizophrenic children.

Li Q, Fallin MD, Louis TA, Lasseter VK, McGrath JA, Avramopoulos D, Wolyniec PS, Valle D, Liang KY, Pulver AE, Ruczinski I.

Genet Epidemiol. 2010 Jul;34(5):396-406. doi: 10.1002/gepi.20488.

PMID:
20568257
44.

The future use of in vitro data in risk assessment to set human exposure standards: challenging problems and familiar solutions.

Crump KS, Chen C, Louis TA.

Environ Health Perspect. 2010 Oct;118(10):1350-4. doi: 10.1289/ehp.1001931. Epub 2010 Jun 18.

45.

Modeling liquid association.

Ho YY, Parmigiani G, Louis TA, Cope LM.

Biometrics. 2011 Mar;67(1):133-41. doi: 10.1111/j.1541-0420.2010.01440.x.

PMID:
20528865
46.

Discussion of "conundrums with uncertainty factors".

Louis TA.

Risk Anal. 2010 Mar;30(3):346-8; author reply 353. doi: 10.1111/j.1539-6924.2010.01365.x. Review. No abstract available.

PMID:
20487392
47.

Childhood Hib vaccination and pneumonia and influenza burden in US seniors.

Cohen SA, Ahmed S, Klassen AC, Agree EM, Louis TA, Naumova EN.

Vaccine. 2010 Jun 17;28(28):4462-9. doi: 10.1016/j.vaccine.2010.04.035. Epub 2010 May 8.

48.
49.

What role for biologically based dose-response models in estimating low-dose risk?

Crump KS, Chen C, Chiu WA, Louis TA, Portier CJ, Subramaniam RP, White PD.

Environ Health Perspect. 2010 May;118(5):585-8. doi: 10.1289/ehp.0901249. Epub 2010 Jan 4. Review.

50.

Trends for influenza and pneumonia hospitalization in the older population: age, period, and cohort effects.

Cohen SA, Klassen AC, Ahmed S, Agree EM, Louis TA, Naumova EN.

Epidemiol Infect. 2010 Aug;138(8):1135-45. doi: 10.1017/S0950268809991506. Epub 2010 Jan 8.

PMID:
20056015

Supplemental Content

Loading ...
Support Center